Genzyme Details Market Potential Of Alemtuzumab For MS

Links shared publicly online about this topic.

  • 583
    total visits

Genzyme Details Market Potential Of Alemtuzumab For MS

medicalnewstoday.com —

Genzyme Corporation (NASDAQ: GENZ) provided an extensive briefing on the market potential of alemtuzumab for multiple sclerosis at an event for investors and analysts in New York. During the two-h

View full resource at medicalnewstoday.com

Tags: Multiple Sclerosis, Genzyme, Event

  • Share

Most Recently Shared on January 14, 2011 at 1:50 am By:

MS_Wisdom2 OrganizedWisdom MS

Genzyme Details Market Potential Of Alemtuzumab For MS: Genzyme Corporation (NASDAQ: GENZ) provided an extensive... http://bit.ly/dWRAWU

1 year ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Multiple Scl MNT Multiple Scl

Genzyme Details Market Potential of Alemtuzumab for MS

businesswire.com — “Press Release Content” View full resource at businesswire.com

  • View Related
  • Share

Most Recently Shared on December 20, 2010 at 7:54 pm By:

GenzymeCorp Genzyme Corporation Pharma

Genzyme Details Market Potential of Alemtuzumab for MS http://bit.ly/gOzvjE

1 year ago...

Reply

Retweet

Favorite

Advertisement